MedTrace Logo

Empowering Latinas to Obtain Breast Cancer Screenings

NCT02964234 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2021-11-18

Study results available
· View outcomes & findings →

Summary

The participatory-based project will quantify the 'added benefit' of an empowerment intervention relative to an education intervention for 150 Latinas on the following outcomes: women's adherence to breast cancer screening guidelines; women's psychosocial facilitators (self-efficacy, norms, support, and knowledge); and women's dissemination of breast health messages throughout their social network. The empowerment intervention will train Latinas in how to discuss breast health with their family and friends and volunteer in local breast health promotion programs. Academic, clinician, and community partners will work together throughout intervention development and evaluation.

Conditions

  • Breastcancer
  • Breast Diseases

Interventions

BEHAVIORAL

Empowerment

Three group sessions (breast cancer education; communication; volunteerism) 1.5 hours 3 times across 3 weeks

BEHAVIORAL

Education

Three group sessions (breast cancer education; diet; physical activity) 1.5 hours 3 times across 3 weeks

Sponsors & Collaborators

  • The Resurrection Project

    collaborator OTHER

  • Juan Diego Centro Comunitario

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Yamile Molina, PhD · University of Illinois at Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
52 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2019-07-24
Completion
2021-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02964234 on ClinicalTrials.gov